Qing Fen
Hg₂Cl₂ (Mercurous chloride)
Also known as: Calomel(English) 轻粉(Chinese)
Ch'ing Fên
Updated October 12, 2026 · Not yet clinically reviewed
Safety at a glance
Graded toxic in our catalogue
7 recorded drug interactions, 5 major or contraindicated
Contraindications or side effects are listed
Traditional Chinese Medicine
- Category
- external applications
- Temperature
- Cold
- Taste
- Pungent
- Channels
- Liver,Kidney,Large Intestine
Functions
Attacks Toxins and Kills Parasites; Relieves Itching; Removes Putridity and Promotes Tissue Regeneration; Absorbs Dampness and Heals Sores; Drastically Purges and Expels Water Accumulation; Promotes Bowel Movement
Traditional uses
Qing Fen (轻粉), Calomelas, is calomel — mercurous chloride, Hg₂Cl₂ — prepared by sublimation. It is acrid and cold and severely toxic (有大毒), entering the Liver, Kidney and Large Intestine channels. It attacks toxins and kills parasites, relieves itching, removes putridity and promotes the regeneration of tissue, absorbs Dampness to heal sores, and drastically purges to expel accumulated Water.
In modern practice it is an external drug. It is applied in ointments and powders to scabies, tinea, stubborn eczema, syphilitic and other chronic sores, and to foul non-healing ulcers, where its parasiticidal and putridity-removing actions are unmatched. The classical internal use — a drastic purge for severe oedema and intractable constipation — carries an unacceptable risk of mercury poisoning and is essentially abandoned; where it is used internally at all the dose is 0.1 to 0.2 g in pill or powder, never decocted, and for one or two doses only.
Mercury is absorbed through broken skin and mucous membranes, so even external use must be limited in area and duration and kept away from large denuded surfaces. It is contraindicated in pregnancy and in debilitated patients, and it must never be swallowed by a patient treating themselves. Poisoning presents with salivation, stomatitis, a metallic taste, bloody diarrhoea, and kidney damage.
Formulas using this herb
4 of 4 formulas
- Shi Jun Zi San
- Tai Yi Gao · 4.50000g
- Yin Du Nei Xiao San · 9.00000g
- Zhou Che Wan 舟车丸 · 3.00000g · assistant
Botanical
Qing Fen is not a plant but calomel, mercury(I) chloride (Hg2Cl2), a toxic heavy-metal compound. It occurs naturally as the rare mineral calomel but in TCM has historically been prepared by subliming a mixture of mercury, sodium chloride, and alum or sulfate. The refined product is a white, heavy, odorless, tasteless powder or fine flaky crystals that darken on exposure to light through partial disproportionation to elemental mercury and mercury(II) chloride. It is sparingly soluble in water. Historical applications included topical treatment of stubborn skin lesions and as a purgative; modern toxicology recognizes calomel as a source of severe acute and chronic mercury poisoning, and contemporary practice strongly discourages its medicinal use (Wikipedia; NCBI).
- Pharmaceutical name
- Calomelas
Constituents
Mercury(I) chloride (calomel, Hg2Cl2)
Inorganic mercurous halide · The 2020 Chinese Pharmacopoeia requires not less than 99.0 percent Hg2Cl2; mercury is about 85 percent of that by mass
The drug substance. Calomel is very poorly soluble in water and so is absorbed far less completely from the gut than mercuric salts, which is the entire basis of its historical reputation as the tolerable mercurial. That reputation is not safety: calomel given as teething powder caused the twentieth-century epidemic of infantile acrodynia, and its purgative action is itself a mercurial irritant effect on the bowel wall rather than a benign osmotic one.
Mercury(II) chloride (corrosive sublimate, HgCl2)
Inorganic mercuric halide, formed by disproportionation · Trace as a manufacturing impurity, rising with light exposure, heating and boiling
The reason calomel cannot be treated as a stable substance. Calomel disproportionates, 2 HgCl going to Hg plus HgCl2, on exposure to light and on boiling with water; the pharmacopoeial description of the drug notes that its colour darkens on standing in light, and that darkening is the visible signature of the reaction. Mercuric chloride is freely water-soluble, corrosive to the gastrointestinal tract and directly nephrotoxic, with a human lethal dose in the range of one to a few grams. A darkened sample of Qing Fen is not simply degraded, it has generated a more dangerous compound in situ.
Metallic mercury (Hg0)
Elemental mercury, the co-product of disproportionation · Trace, co-formed with mercuric chloride
Finely divided elemental mercury released within the preparation. In the gut it is poorly absorbed, but any that volatilises is absorbed efficiently through the lungs and crosses the blood-brain barrier, and it can be oxidised to Hg2+ intracellularly. Its presence is one reason grinding and storing the drug is not a neutral act.
Ionic mercury (Hg2+) liberated in the gastrointestinal tract
Bioavailable divalent mercury cation · A small but real fraction of the administered dose
The species that actually poisons. Divalent mercury binds thiol groups indiscriminately, concentrates in the proximal renal tubule, and in chronic exposure provokes an immune-mediated glomerular lesion. In a Chinese retrospective series of 172 mercury-poisoned patients, 46 had renal damage, 41 of those presented with nephrotic syndrome, and membranous nephropathy was the dominant biopsy finding in 18 of 35 patients biopsied.
Residual alum and sodium chloride from the sublimation charge
Process residues (potassium aluminium sulfate, sodium chloride) · Variable in traditionally sublimed material; negligible in pharmacopoeial-grade product
Calomel is made by subliming mercury with alum and common salt, and the historical furnace method leaves those reagents behind in the crystalline cake. They are not toxicologically important in themselves, but their presence marks material that has not been assayed and whose mercury speciation is unknown.
Drug interactions
Hong Fen (red mercuric oxide, HgO) confused with or substituted for Qing Fen
Major · Potentially fatal: an external-only mercuric compound given at an internal mercurous dose · Evidence level: Established
These are two different mercurials with opposite handling rules and they are routinely conflated, including in reference sources: some databases describe Hong Fen as calomel, which is wrong. Hong Fen is red mercuric oxide, HgO, assayed in the 2020 Chinese Pharmacopoeia at not less than 99.0 percent HgO, classed you da du (gravely toxic), permitted for external use only, prohibited for internal use, prohibited for prolonged external use, and contraindicated in pregnancy. Qing Fen is mercurous chloride, Hg2Cl2, also assayed at not less than 99.0 percent, and the same pharmacopoeia does permit an internal dose of 0.1 to 0.2 g per administration once or twice daily in pills or capsules. A practitioner who reads a record calling Hong Fen calomel, and applies the calomel internal dose to it, is giving a divalent mercuric compound by mouth at a dose authorised only for a far less soluble mercurous one. Both drugs are separately listed in Schedule 1 of the Hong Kong Chinese Medicine Ordinance, as Calomelas and Hydrargyri Oxydum Rubrum respectively, and both appear separately in the 28 toxic substances of Chinese State Council Decree No. 23; the regulators treat them as distinct because they are.
Clinical note: Verify the Latin name and the assay on the label, not the pinyin. Calomelas is Hg2Cl2 and may be given internally at 0.1 to 0.2 g under the pharmacopoeial restrictions; Hydrargyri Oxydum Rubrum is HgO and must never be given internally at all. Also distinguish both from Bai Jiang Dan (Hydrargyrum Chloratum Compositum) and from Zhu Sha (Cinnabaris, HgS).
Potassium iodide, iodine tincture and potassium bromide
Major · Serious: converts the drug in situ to a more toxic mercuric halide · Evidence level: Established
A classical and chemically unavoidable pharmaceutical incompatibility. Calomel triturated or co-administered with an iodide is converted to mercuric iodide, and with a bromide to mercuric bromide, in both cases with liberation of metallic mercury and visible darkening of the mixture. The mercuric halides are far more soluble and far more toxic than the mercurous chloride that was dispensed. Nineteenth and twentieth century pharmacy texts recorded that there is no formulation trick that prevents the decomposition and that the combination should simply never be prescribed.
Clinical note: Do not co-prescribe or co-compound with any iodide or bromide, including iodine-containing expectorants, potassium iodide for thyroid protection, iodinated contrast preparations taken orally, or seaweed-derived iodine supplements.
Cinnabar (Zhu Sha, HgS) and other mercury-containing patent medicines
Major · Serious: cumulative, unmeasured mercury burden · Evidence level: Established
Mercurials are widespread in Chinese patent medicines, and calomel and cinnabar are the two most commonly used (Kang-Yum 1992). In a Chinese series of 288 chronic mercury poisoning patients, Chinese folk remedies were one of the three principal exposure routes alongside occupational exposure and skin-lightening cosmetics, and the nephrotic syndrome caused specifically by folk remedies was predominantly membranous nephropathy, with a higher rate of peripheral neuropathy than other causes (Sun 2021). Mercury from separate products is additive in the same renal and neurological compartments.
Clinical note: Take an explicit patent-medicine, folk-remedy and skin-cream history. Measure blood and 24-hour urine mercury before assuming the exposure is confined to what you prescribed.
Dimercaprol, unithiol (DMPS), succimer (DMSA) and penicillamine
Major · Opposing pharmacology: these are the antidotes to the drug · Evidence level: Established
Dithiol and thiol chelators are the definitive treatment of mercury poisoning and act by competing for the thiol binding that mercury exploits. Chelation was the main treatment in 41 patients with mercury-induced nephrotic syndrome, with an overall effective rate of 97.5 percent (Gao 2022), and recovery is generally good but slow, taking a mean of roughly 23 months for nephrotic syndrome and 38 months for confirmed neurological injury (Sun 2021). A patient on a chelator has mercury poisoning, and continuing the source drug directly opposes the treatment.
Clinical note: Stop the mercurial. Chelation is a hospital decision guided by blood and 24-hour urine mercury, not a licence to continue exposure.
Nephrotoxic drugs (NSAIDs, aminoglycosides, ciclosporin, tacrolimus, iodinated contrast media)
Major · Serious: additive injury to the organ mercury preferentially damages · Evidence level: Probable
Divalent mercury concentrates in the proximal tubule and produces both tubular injury and an immune-mediated membranous glomerulopathy; renal damage occurred in 26.7 percent of mercury-poisoned patients in a six-year Chinese series (Gao 2022). Any concurrent nephrotoxin acts on the same organ, and because mercury is cleared renally, falling renal function raises mercury retention, creating a feedback loop. Iodinated contrast carries the additional chemical incompatibility noted above.
Clinical note: Check baseline creatinine and urine protein. Unexplained nephrotic-range proteinuria in a patient taking Chinese mineral medicines should prompt mercury measurement before a renal biopsy is interpreted as idiopathic membranous nephropathy.
Purgatives, laxatives and diuretics
Moderate · Additive fluid and electrolyte loss on top of a drug whose action is drastic purgation · Evidence level: Probable
The internal indication for Qing Fen is itself drastic purgation and diuresis. Calomel's cathartic effect is a mercurial irritant action on the intestinal mucosa rather than a bulk or osmotic effect, so the diarrhoea it produces is a sign of local toxicity. Compounding it with other purgatives or with diuretics risks hypovolaemia and hypokalaemia, and hypovolaemia in turn concentrates mercury delivery to an already vulnerable kidney.
Clinical note: Do not stack purgatives. The pharmacopoeial instruction to rinse the mouth after an internal dose exists because the drug is corrosive to mucosa; treat any diarrhoea as toxicity rather than therapeutic effect.
Antacids, proton pump inhibitors and other drugs raising gastric or intestinal pH
Theoretical · Possible increase in the soluble, absorbable mercury fraction · Evidence level: Theoretical
Calomel's low absorption depends on its low solubility, and mercurous chloride is decomposed to more soluble species by alkali. Whether clinically meaningful conversion occurs at achievable intestinal pH in humans has not been measured for this drug, so this is flagged as theoretical rather than demonstrated. It is recorded because absence of an assay is not evidence of absence, and because the analogous pH dependence has been shown for the arsenic sulfide mineral realgar.
Clinical note: Treat as an unquantified additional uncertainty rather than a quantified risk. It is one more reason not to dose this drug internally outside a setting that can measure mercury.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| topical | Appropriate amount | — | ChP 2025. 外用适量,研末掺敷患处 — the primary route. Toxic; not to be used in excess; contraindicated in pregnancy. Corrected from a generic 'As needed' poultice filler value generated from tcm_category. |
| pill or capsule | 0.1–0.2 g | 1–2 times daily | ChP 2025. 内服每次0.1~0.2g,一日1~2次,多入丸剂或装胶囊服,服后漱口 — internal use only with caution, 1–2 times daily, in pills or capsules, rinsing the mouth afterwards. Mercurous chloride. |
Evidence
Study design on record, not certainty of outcome.
- Observational / case report
- 8
Toxic Nephropathy Secondary to Chronic Mercury Poisoning: Clinical Characteristics and Outcomes
Gao Z, Wu N, Du X, Li H, Mei X, Song Y · Kidney International Reports · 2022 · cohort
Observational / case report · Not yet verified
Retrospective analysis of 172 patients diagnosed with mercury poisoning at a Beijing centre over six years. Renal damage occurred in 46 patients (26.7 percent); of those, 41 presented with nephrotic syndrome and 5 with isolated proteinuria, and membranous nephropathy was the dominant pathology in 18 of 35 biopsies (51.4 percent). Chelation was the mainstay of treatment with an overall effective rate of 97.5 percent. The authors emphasise that mercury nephropathy is commonly misdiagnosed and missed, which matters directly for practitioners whose patients take mercurial minerals.
Epidemiology, clinical presentation, treatment, and follow-up of chronic mercury poisoning in China: a retrospective analysis
Sun Y, Long J, Zhao J, Peng X, Qiu Z · BMC Pharmacology and Toxicology · 2021 · cohort
Observational / case report · Not yet verified
Retrospective study of 288 patients with mercury poisoning treated at a Chinese military general hospital between 2014 and 2019. Chinese folk remedies were identified as one of the three principal exposure sources alongside occupational exposure and mercury-containing cosmetics. Nervous system involvement was commonest (50.3 percent), then renal (16.4 percent) and respiratory (8.0 percent); nephrotic syndrome caused by folk remedies was predominantly membranous nephropathy, and peripheral neuropathy was more frequent from folk remedies than from other exposure routes. Recovery was possible but slow, taking a mean of about 23 months for nephrotic syndrome and about 38 months for confirmed neurological injury. The authors call explicitly for improved safety surveillance of folk remedies.
Mercury Toxicity and Contamination of Households from the Use of Skin Creams Adulterated with Mercurous Chloride (Calomel)
Copan L, Fowles J, Barreau T, McGee N · International Journal of Environmental Research and Public Health · 2015 · cohort
Observational / case report · Not yet verified
Public health investigation of Californian households using imported skin creams adulterated with calomel, documenting elevated urinary mercury in users and in household members who never applied the cream, together with mercury vapour contamination of the homes themselves. It establishes that calomel is not a self-limited exposure confined to the person taking it, and that mercurous chloride in a topical preparation generates absorbable mercury in the domestic environment.
MERCURY IN THE URINE OF CHILDREN WITH ACRODYNIA
Warkany J, Hubbard DM · The Lancet · 1948 · cohort
Observational / case report · Not yet verified
The study that identified mercury as the cause of infantile acrodynia, or pink disease. Quantitative urinary mercury was raised in the great majority of affected children, and the exposure was traced principally to calomel teething powders and calomel-containing anthelmintics. Acrodynia developed in roughly one in 500 exposed children and killed a substantial minority of those affected; the syndrome essentially disappeared after calomel was removed from teething powders in the mid-1950s. This is the definitive demonstration that mercurous chloride, the supposedly safe mercurial, causes severe and sometimes fatal mercury poisoning in children at ordinary medicinal doses.
Acrodynia and mercury
Warkany J, Hubbard DM · The Journal of Pediatrics · 1953 · cohort
Observational / case report · Not yet verified
Extended clinical and analytical series consolidating the mercury aetiology of acrodynia, correlating the syndrome with mercury exposure from calomel-containing preparations and describing the clinical picture: painful red swollen hands and feet, rash, sweating, tachycardia, hypertension, photophobia, profound irritability, anorexia, insomnia and marked proximal muscle weakness. It is the reference description of chronic mercurous chloride poisoning in children.
Acrodynia and Excessive Intake of Mercury
Dathan JG · BMJ · 1954 · cohort
Observational / case report · Not yet verified
British clinical report linking acrodynia to mercury intake, part of the sequence of work that led to calomel being withdrawn from proprietary teething powders. It documents the dose-response problem directly: the mercurial was being given at conventional, label-recommended amounts, and the poisoning followed anyway in susceptible children.
Membranous nephropathy due to chronic mercury poisoning from traditional Indian medicines: report of five cases
Doshi M, Annigeri RA, Kowdle PC, Subba Rao B, Varman M · Clinical Kidney Journal · 2018 · cohort
Observational / case report · Not yet verified
Five biopsy-proven cases of membranous nephropathy attributable to mercury in traditional Indian medicines, with proteinuria resolving after the medicines were stopped and chelation given. The species and system differ from Chinese calomel practice, but the lesion, the mechanism and the source category are the same, and the series makes the point that mercurial nephropathy from a traditional preparation is reversible only if someone thinks to ask what the patient is taking.
Lead, Mercury, and Arsenic Poisoning Due to Topical Use of Traditional Chinese Medicines
Wu ML, Deng JF, Lin KP, Tsai WJ · The American Journal of Medicine · 2013 · cohort
Observational / case report · Verified
Two toxicologically confirmed cases of systemic heavy-metal poisoning from mucocutaneous application of Chinese mineral medicines. In the first, a 51-year-old man applied a hong-dan mixture containing lead tetraoxide, arsenic and mercury into an anal fistula for two weeks and developed perianal gangrene, rash, anaemia, hair loss, peripheral neuropathy and muscle atrophy, with raised urine mercury and arsenic; DMPS gave only partial recovery and the neuropathy persisted four years later. The relevance to Qing Fen is direct: the external route is not a safe route, and application to damaged or infected tissue is the worst case.
Safety
Toxicity: toxic
Contraindications
Don’t use overdose. Its use should be cautious for taking orally, and prohibited in pregnant women.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 412–415.
Cultural and historical
Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen, stone section, entry for shui yin fen (mercury powder), of which qing fen is an alias · Ming dynasty, compiled to 1578, first printed 1596
Mei Chuang Mi Lu (Secret Record of Syphilitic Sores), Chen Sicheng · Ming dynasty, 1632 (fifth year of the Chongzhen reign)
Zhonghua Renmin Gongheguo Yaodian (Pharmacopoeia of the People's Republic of China), 2020 edition, monograph for Qing Fen (Calomelas) · People's Republic of China, 2020
Yiliao Yong Duxing Yaopin Guanli Banfa (Measures for the Administration of Toxic Drugs for Medical Use), State Council Decree No. 23 · People's Republic of China, promulgated 27 December 1988
References
- Dally A. The Rise and Fall of Pink Disease. Social History of Medicine. 1997 doi:10.1093/shm/10.2.291
- Kang-Yum E, Oransky SH. Chinese patent medicine as a potential source of mercury poisoning. Veterinary and Human Toxicology. 1992
- Ko RJ. Adulterants in Asian Patent Medicines. New England Journal of Medicine. 1998 doi:10.1056/nejm199809173391214
- Chinese Medicine Regulatory Office, Department of Health, Hong Kong SAR. General Knowledge of Toxic Chinese Herbal Medicines: the 31 toxic Chinese herbal medicines in Schedule 1 of the Chinese Medicine Ordinance (Cap. 549). Chinese Medicine Regulatory Office, Hong Kong SAR Government. 2024
- State Council of the People's Republic of China. Yiliao Yong Duxing Yaopin Guanli Banfa (Measures for the Administration of Toxic Drugs for Medical Use), State Council Decree No. 23. Government of the People's Republic of China. 1988
- United Nations Environment Programme. Minamata Convention on Mercury: Text and Annexes. United Nations Environment Programme, Geneva. 2013